Purchases and Sales Made in Q1 2022 in Cyclo Therapeutics, Inc. (CYTH)
This table provides information about the institutional ownership of Cyclo Therapeutics, Inc. (CYTH) during Q1 2022. The information is specifically focused on institutions that hold shares of Cyclo Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2022
Q1 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
9.49K+ 14.31% |
$24.9K - $42.8K
|
75.8K
$56.8K
|
|
|
May 12, 2022
Q1 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
4.35K+ 31.42% |
$11.4K - $19.6K
|
18.2K
$13.7K
|
|
|
May 16, 2022
Q1 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2.01K+ 5586.11% |
$5.27K - $9.07K
|
2.05K
$1.54K
|
|
|
May 13, 2022
Q1 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
1.47K+ 3.13% |
$3.85K - $6.62K
|
48.3K
$36.2K
|
|
|
May 12, 2022
Q1 2022
|
Citigroup Inc
|
BUY
|
- |
1.23KNew |
$3.23K - $5.56K
|
1.23K
$924
|
|
|
May 12, 2022
Q1 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
836+ 124.4% |
$2.19K - $3.77K
|
1.51K
$1.13K
|
|
|
May 13, 2022
Q1 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
764+ 0.3% |
$2K - $3.45K
|
255K
$191K
|
|
|
Oct 27, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
60+ 13.54% |
$157 - $271
|
503
$377
|
|
|
May 09, 2022
Q1 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 13, 2022
Q1 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-300- 37.36% |
$786 - $1.35K
|
503
$377
|
|
|
May 16, 2022
Q1 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-10.2KClosed |
$26.7K - $46K
|
0
$0
|
|
|
May 16, 2022
Q1 2022
|
Ubs Group Ag
|
SELL
|
- |
-10.6K- 82.26% |
$27.8K - $47.9K
|
2.29K
$1.72K
|
|
|
May 17, 2022
Q1 2022
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-22.2KClosed |
$58.3K - $100K
|
0
$0
|